Anke van den Berg
Impact in
- Cancer Research top 0.1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment
Papers in
-
- RNA modifications and cancer 29
- Renal and related cancers 26
-
- Lymphoma Diagnosis and Treatment 104
- Co-authors
- CDM Fletcher (1 shared paper)Ineke Molenaar (1 shared paper)Sibrand Poppema (58 shared papers)Joost Kluiver (75 shared papers)Arjan Diepstra (94 shared papers)Bart‐Jan Kroesen (30 shared papers)Lydia Visser (68 shared papers)S Poppema (13 shared papers)
- Journals
- Blood (29 papers)PLoS ONE (19 papers)Cancers (17 papers)Genes Chromosomes and Cancer (13 papers)The Journal of Pathology (8 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Anke van den Berg
322 papers receiving 16.8k citations
Anke van den Berg's Hit Papers
Peers
Comparison fields: 5 of 166
- Cancer Research 4.1k
- Pathology and Forensic Medicine 3.8k
- Oncology 4.5k
- Genetics 1.3k
- Immunology 2.5k
Countries citing papers authored by Anke van den Berg
This map shows the geographic impact of Anke van den Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke van den Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke van den Berg more than expected).
Fields of papers citing papers by Anke van den Berg
This network shows the impact of papers produced by Anke van den Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke van den Berg. The network helps show where Anke van den Berg may publish in the future.
Co-authors
The 25 scholars most cited alongside Anke van den Berg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 337 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | World Health Organization Classification of Tumours Hit paper breakdown → | 2002 | 5788 |
| 2 | BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas Hit paper breakdown → | 2005 | 551 |
| 3 | 1994 | 307 | |
| 4 | 1999 | 298 | |
| 5 | 2006 | 241 | |
| 6 | 2010 | 222 | |
| 7 | 2003 | 192 | |
| 8 | 2012 | 188 | |
| 9 | 2005 | 183 | |
| 10 | 2009 | 181 | |
| 11 | 2010 | 174 | |
| 12 | 2016 | 146 | |
| 13 | 2014 | 139 | |
| 14 | 1993 | 134 | |
| 15 | 1996 | 134 | |
| 16 | 2016 | 130 | |
| 17 | 2002 | 126 | |
| 18 | 2009 | 118 | |
| 19 | 2012 | 115 | |
| 20 | 2016 | 114 |
About Anke van den Berg
Anke van den Berg is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Cancer Research, Oncology and Immunology, having authored 337 papers that have together received 17.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (104 papers), Immune Cell Function and Interaction (45 papers), Cancer-related molecular mechanisms research (35 papers), Viral-associated cancers and disorders (35 papers), MicroRNA in disease regulation (34 papers), RNA modifications and cancer (29 papers), Cancer Genomics and Diagnostics (27 papers) and Renal and related cancers (26 papers). The work is most often cited by research in Cancer Research (4.1k citations), Pathology and Forensic Medicine (3.8k citations), Oncology (4.5k citations), Genetics (1.3k citations) and Immunology (2.5k citations). Anke van den Berg has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include CDM Fletcher, Ineke Molenaar, Sibrand Poppema, Joost Kluiver, Arjan Diepstra, Bart‐Jan Kroesen, Lydia Visser, S Poppema, Debora de Jong and Tjasso Blokzijl. Their work appears in journals such as Blood, PLoS ONE, Cancers, Genes Chromosomes and Cancer and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.